For the Inventor, By the Inventor

Enter assignee name

Morrisville, NC, United States of America

Liquidia Technologies, Inc.

USPTO Granted Patents = 22

EPO Patents = 5

Trademarks = 4

Forward Citations = 122

Loading Chart...

Loading Chart...

18 inventors (with patents filed for the assignee):

Benjamin Maynor (16 out of 26 patents)

Robert L Henn (10 out of 22 patents)

Jason P Rolland (9 out of 91 patents)

4. Jacob J Sprague (9 out of 9 patents)

5. Brian T Farrer (6 out of 6 patents)

6. Robert Frank Roscigno (6 out of 7 patents)

7. Alexander Ermochkine (3 out of 3 patents)

8. Alex Ermoshkin (3 out of 3 patents)

9. Derek A Schorzman (3 out of 30 patents)

10. Ginger Denison Rothrock (2 out of 30 patents)

11. Kyle Henn (2 out of 2 patents)

12. Lloyd Mahlon Robeson (2 out of 127 patents)

13. Robert Praino (2 out of 2 patents)

14. Andrew J Murphy (1 out of 3 patents)

15. Matthew Craig Parrott (1 out of 11 patents)

22 patents: Sort by Forward Citations

1. 12390475 - Dry powder treprostinil for the treatment of pulmonary hypertension (2025-08-19),

2. 11744836 - Dry powder treprostinil for the treatment of pulmonary hypertension (2023-09-05),

3. 11744835 - Dry powder treprostinil for the treatment of pulmonary hypertension (2023-09-05),

4. 11712442 - Dry powder treprostinil for the treatment of pulmonary hypertension (2023-08-01),

5. 11660304 - Dry powder treprostinil for the treatment of pulmonary hypertension (2023-05-30),

6. 10898494 - Dry powder treprostinil for the treatment of pulmonary hypertension (2021-01-26),

7. 10717209 - Methods and materials for fabricating laminate nanomolds and nanoparticles therefrom (2020-07-21),

8. 9744715 - Method for producing patterned materials (2017-08-29),

9. 9662809 - Methods and materials for fabricating laminate nanomolds and nanoparticles therefrom (2017-05-30),

10. 9545737 - System and method for producing particles and patterned films (2017-01-17),

11. 9340001 - Methods and materials for fabricating laminate nanomolds and nanoparticles therefrom (2016-05-17),

12. 9314548 - Nanostructured surfaces for biomedical/biomaterial applications and processes thereof (2016-04-19),

13. 9205594 - Method for producing patterned materials (2015-12-08),

14. 8945527 - Degradable compounds and methods of use thereof, particularly with particle replication in non-wetting templates (2015-02-03),

15. 8945441 - Methods and materials for fabricating laminate nanomolds and nanoparticles therefrom (2015-02-03),

Company Overview

Liquidia Technologies, Inc. is a biopharmaceutical company based in Morrisville, North Carolina, specializing in the development of innovative therapies for patients with serious pulmonary and other diseases. The company leverages its proprietary PRINT technology platform to create drug formulations that enhance the delivery and efficacy of therapeutic agents. Liquidia is committed to advancing its pipeline of products through rigorous research and development, aiming to address unmet medical needs in the respiratory disease space.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

22 Patents

#20 in Morrisville, NC

#339 in North Carolina

#15,037 in US

#28,782 in the World

Morrisville, NC, United States of America

Liquidia Technologies, Inc.

Forward Citations = 122

18 inventors:

Benjamin Maynor (16 out of 26 patents)

Robert L Henn (10 out of 22 patents)

Jason P Rolland (9 out of 91 patents)

4. Jacob J Sprague (9 out of 9 patents)

5. Brian T Farrer (6 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Liquidia Technologies, Inc.. Retrieved from https://idiyas.com/company/liquidia-technologies

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…